CN117794559A - 非囊性纤维化支气管扩张的治疗 - Google Patents

非囊性纤维化支气管扩张的治疗 Download PDF

Info

Publication number
CN117794559A
CN117794559A CN202280053442.5A CN202280053442A CN117794559A CN 117794559 A CN117794559 A CN 117794559A CN 202280053442 A CN202280053442 A CN 202280053442A CN 117794559 A CN117794559 A CN 117794559A
Authority
CN
China
Prior art keywords
cms
ncfb
colistin
cba
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280053442.5A
Other languages
English (en)
Chinese (zh)
Inventor
P·卡斯特兰尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of CN117794559A publication Critical patent/CN117794559A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202280053442.5A 2021-08-05 2022-08-04 非囊性纤维化支气管扩张的治疗 Pending CN117794559A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189819.2A EP4129322A1 (en) 2021-08-05 2021-08-05 Treatment of non-cystic fibrosis bronchiectasis
EP21189819.2 2021-08-05
PCT/EP2022/071960 WO2023012280A1 (en) 2021-08-05 2022-08-04 Treatment of non-cystic fibrosis bronchiectasis

Publications (1)

Publication Number Publication Date
CN117794559A true CN117794559A (zh) 2024-03-29

Family

ID=77226670

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280053442.5A Pending CN117794559A (zh) 2021-08-05 2022-08-04 非囊性纤维化支气管扩张的治疗

Country Status (8)

Country Link
US (1) US20240342239A1 (https=)
EP (2) EP4129322A1 (https=)
JP (1) JP2024527021A (https=)
CN (1) CN117794559A (https=)
AU (1) AU2022324695A1 (https=)
BR (1) BR112024001945A2 (https=)
CA (1) CA3226916A1 (https=)
WO (1) WO2023012280A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers

Also Published As

Publication number Publication date
EP4129322A1 (en) 2023-02-08
WO2023012280A1 (en) 2023-02-09
JP2024527021A (ja) 2024-07-19
BR112024001945A2 (pt) 2024-04-30
US20240342239A1 (en) 2024-10-17
EP4380592A1 (en) 2024-06-12
CA3226916A1 (en) 2023-02-09
AU2022324695A1 (en) 2024-02-29

Similar Documents

Publication Publication Date Title
Cymbala et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis
RU2563809C2 (ru) Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
Mainz et al. Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis—results of a multicenter, prospective, randomized, double-blind, controlled trial
JP2008503500A (ja) 気管支感染症の治療法
Elborn et al. Bronchiectasis and inhaled tobramycin: a literature review
HK1254627A1 (en) Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
Bourdet et al. Key concepts
US20240226112A1 (en) Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosis
CN109789193A (zh) 使用间α抑制蛋白治疗肺病的方法
CN117794559A (zh) 非囊性纤维化支气管扩张的治疗
Terzano et al. Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma
US7973029B2 (en) Inhaled aztreonam lysine for the treatment of deficits in health-related quality-of-life in lung diseases
US12178841B2 (en) Treatment of non-cystic fibrosis bronchiectasis
Zhang et al. Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: a prospective multicenter cohort study
EA052469B1 (ru) Лечение некистозных фиброзных (немуковисцидозных) бронхоэктазов
JP2010540539A5 (https=)
CN114129705B (zh) 一种多肽在预防和治疗肺炎的药物中的应用
Haworth et al. Two randomised controlled trials of inhaled liposomal ciprofloxacin (ARD-3150) in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas Aeruginosa
RU2356574C1 (ru) Способ лечения больных бронхиальной астмой
Greenstone Changing paradigms in the diagnosis and management of bronchiectasis
Hoppentocht et al. Tolerability and pharmacokinetic evaluation of inhaled dry powder tobramycin free base in patients with non-cystic fibrosis bronchiectasis
Bush et al. 8. NEBULIZERS IN CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS IN CHILDREN AND ADULTS: THERAPIES
Kuebler et al. Pulmonary disease
Wainwright Aztreonam Lysine: An Inhalational Antibiotic in Cystic Fibrosis
TW201929895A (zh) 使用間-α抑制蛋白治療肺病之方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination